Goldman Sachs’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $16.9M | Sell |
34,300
-66,700
| -66% | -$36.2M | ﹤0.01% | 2595 |
|
|
2025
Q4 | $58.5M | Buy |
101,000
+82,100
| +434% | +$46.4M | 0.01% | 1380 |
|
|
2025
Q3 | $9.17M | Buy |
18,900
+16,300
| +627% | +$7.59M | ﹤0.01% | 3046 |
|
|
2025
Q2 | $1.05M | Buy |
2,600
+1,600
| +160% | +$669K | ﹤0.01% | 4657 |
|
|
2025
Q1 | $498K | Sell |
1,000
-4,500
| -82% | -$2.44M | ﹤0.01% | 5187 |
|
|
2024
Q4 | $2.86M | Buy |
5,500
+1,000
| +22% | +$550K | ﹤0.01% | 3987 |
|
|
2024
Q3 | $2.78M | Sell |
4,500
-1,500
| -25% | -$888K | ﹤0.01% | 3848 |
|
|
2024
Q2 | $3.32M | Sell |
6,000
-6,100
| -50% | -$3.49M | ﹤0.01% | 3530 |
|
|
2024
Q1 | $7.03M | Sell |
12,100
-19,700
| -62% | -$11.1M | ﹤0.01% | 2795 |
|
|
2023
Q4 | $16.9M | Buy |
31,800
+11,500
| +57% | +$5.57M | ﹤0.01% | 2061 |
|
|
2023
Q3 | $10.3M | Buy |
20,300
+9,700
| +92% | +$5.17M | ﹤0.01% | 2365 |
|
|
2023
Q2 | $5.53M | Sell |
10,600
-19,900
| -65% | -$10.7M | ﹤0.01% | 3015 |
|
|
2023
Q1 | $17.6M | Sell |
30,500
-108,500
| -78% | -$61.2M | ﹤0.01% | 1930 |
|
|
2022
Q4 | $76.5M | Buy |
139,000
+111,500
| +405% | +$59.1M | 0.02% | 870 |
|
|
2022
Q3 | $13.9M | Buy |
27,500
+10,600
| +63% | +$5.93M | ﹤0.01% | 2188 |
|
|
2022
Q2 | $9.18M | Sell |
16,900
-7,700
| -31% | -$4.24M | ﹤0.01% | 2600 |
|
|
2022
Q1 | $14.5M | Sell |
24,600
-18,600
| -43% | -$10.7M | ﹤0.01% | 2325 |
|
|
2021
Q4 | $28.8M | Buy |
43,200
+28,600
| +196% | +$17.9M | 0.01% | 1799 |
|
|
2021
Q3 | $8.34M | Sell |
14,600
-500
| -3% | -$274K | ﹤0.01% | 2893 |
|
|
2021
Q2 | $7.62M | Sell |
15,100
-3,600
| -19% | -$1.7M | ﹤0.01% | 2961 |
|
|
2021
Q1 | $8.53M | Sell |
18,700
-5,600
| -23% | -$2.67M | ﹤0.01% | 2695 |
|
|
2020
Q4 | $11.3M | Buy |
24,300
+700
| +3% | +$328K | ﹤0.01% | 2358 |
|
|
2020
Q3 | $10.4M | Sell |
23,600
-1,600
| -6% | -$661K | ﹤0.01% | 2289 |
|
|
2020
Q2 | $9.13M | Sell |
25,200
-12,400
| -33% | -$4.16M | ﹤0.01% | 2344 |
|
|
2020
Q1 | $10.7M | Buy |
37,600
+35,400
| +1,609% | +$11.2M | ﹤0.01% | 2045 |
|
|
2019
Q4 | $715K | Sell |
2,200
-38,200
| -95% | -$11.6M | ﹤0.01% | 4311 |
|
|
2019
Q3 | $11.8M | Buy |
40,400
+19,500
| +93% | +$5.58M | ﹤0.01% | 2197 |
|
|
2019
Q2 | $6.14M | Buy |
20,900
+5,900
| +39% | +$1.63M | ﹤0.01% | 2710 |
|
|
2019
Q1 | $4.11M | Sell |
15,000
-3,400
| -18% | -$846K | ﹤0.01% | 3138 |
|
|
2018
Q4 | $4.12M | Sell |
18,400
-22,100
| -55% | -$5.19M | ﹤0.01% | 3046 |
|
|
2018
Q3 | $9.88M | Buy |
40,500
+18,100
| +81% | +$4.16M | ﹤0.01% | 2469 |
|
|
2018
Q2 | $4.64M | Buy |
22,400
+4,200
| +23% | +$892K | ﹤0.01% | 3014 |
|
|
2018
Q1 | $3.76M | Sell |
18,200
-14,600
| -45% | -$3.06M | ﹤0.01% | 3119 |
|
|
2017
Q4 | $6.23M | Sell |
32,800
-25,500
| -44% | -$4.89M | ﹤0.01% | 2819 |
|
|
2017
Q3 | $11M | Buy |
58,300
+45,200
| +345% | +$8.19M | ﹤0.01% | 2484 |
|
|
2017
Q2 | $2.29M | Sell |
13,100
-113,600
| -90% | -$19.1M | ﹤0.01% | 3738 |
|
|
2017
Q1 | $19.5M | Buy |
126,700
+74,700
| +144% | +$11.4M | 0.01% | 1901 |
|
|
2016
Q4 | $7.34M | Buy |
52,000
+10,300
| +25% | +$1.52M | ﹤0.01% | 2712 |
|
|
2016
Q3 | $6.63M | Sell |
41,700
-38,700
| -48% | -$5.96M | ﹤0.01% | 2788 |
|
|
2016
Q2 | $11.9M | Buy |
80,400
+64,500
| +406% | +$9.52M | ﹤0.01% | 2184 |
|
|
2016
Q1 | $2.25M | Sell |
15,900
-115,700
| -88% | -$15.5M | ﹤0.01% | 3364 |
|
|
2015
Q4 | $18.7M | Sell |
131,600
-10,600
| -7% | -$1.41M | 0.01% | 1797 |
|
|
2015
Q3 | $17.4M | Sell |
142,200
-166,900
| -54% | -$21.7M | 0.01% | 1809 |
|
|
2015
Q2 | $40.1M | Sell |
309,100
-170,300
| -36% | -$22.2M | 0.01% | 1275 |
|
|
2015
Q1 | $64.4M | Buy |
479,400
+168,700
| +54% | +$21.7M | 0.02% | 909 |
|
|
2014
Q4 | $38.9M | Buy |
310,700
+16,300
| +6% | +$1.98M | 0.01% | 1312 |
|
|
2014
Q3 | $35.8M | Buy |
294,400
+262,100
| +811% | +$31.9M | 0.01% | 1329 |
|
|
2014
Q2 | $3.81M | Sell |
32,300
-88,200
| -73% | -$10.4M | ﹤0.01% | 3327 |
|
|
2014
Q1 | $14.5M | Buy |
120,500
+55,900
| +87% | +$6.65M | ﹤0.01% | 2045 |
|
|
2013
Q4 | $7.19M | Buy |
64,600
+11,800
| +22% | +$1.17M | ﹤0.01% | 2679 |
|
|
2013
Q3 | $4.87M | Sell |
52,800
-32,700
| -38% | -$2.96M | ﹤0.01% | 2950 |
|
|
2013
Q2 | $7.24M | Buy |
+85,500
| New | +$7.12M | ﹤0.01% | 2372 |
|
Other funds holding TMO
VCM
Goldman Sachs's TMO Position: Q1 2026 in Review
Goldman Sachs increased its Thermo Fisher Scientific (TMO) stake by 2.9% in Q1 2026, buying an estimated $49M and bringing the position to 3,157,226 shares worth $1.55B. The position accounts for 0.18% of the portfolio, ranked #91.
Goldman Sachs first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.78B in Q4 2025. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Goldman Sachs held 3,157,226 shares of Thermo Fisher Scientific worth $1.55B as of Q1 2026.
- Goldman Sachs bought 90,342 Thermo Fisher Scientific shares in Q1 2026, an estimated $49M.
- Thermo Fisher Scientific made up 0.18% of Goldman Sachs's portfolio in Q1 2026, its #91 holding.
- Goldman Sachs first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
- Goldman Sachs's Thermo Fisher Scientific position peaked at $1.78B in Q4 2025.
- 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.